Vascular endothelial growth factor-111 (VEGF-111) and tendon healing: Preliminary results in a rat model of tendon injury

Muscles, Ligaments and Tendons Journal

Volumn 4, Issue 1, 2014, Pages 24-28

  Kaux, Jean François ^a   Janssen, Lauriane ^b   Drion, Pierre ^b   Nusgens, Betty ^b   Libertiaux, Vincent ^b   Pascon, Frédéric ^b   Heyeres, Antoine ^b   Hoffmann, Audrey ^b   Lambert, Charles ^b   Refidaff, Cref ^a   Denoël, Vincent ^b   Defraigne, Jean Olivier ^c   Rickert, Markus ^d   Crielaard, Jean Michel ^a   Colige, Alain ^b  

^a University and University Hospital of Liège   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c CREDEC Pathology Tower B23   (Belgium)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Biomechanical; Growth factor; Healing; Tendon; VEGF; VEGF 111

Indexed keywords

EID: 84900027943     PISSN: None     EISSN: 22404554     Source Type: Journal    
DOI: 10.32098/mltj.01.2014.05     Document Type: Article

References (19)

1. Kaux JF, et al. Current opinion on tendinopathy. Journal of Sports Science and Medicine. 2011;10:238-253.
2. Kaux JF, Crielaard JM. Platelet-rich plasma application in the management of chronic tendinopathies. Acta Orthop Belg, 2013;79(1):10-15.
3. Mineur P, et al. Newly identified biologically active and proteol-ysis-resistant VEGF-A isoform VEGF111 is induced by geno-toxic agents. J Cell Biol 2007;179(6):1261-1273.
4. Lambert CA, Mineur P, Nusgens BV, [VEGF111: Dr Jekyll and Mr Hyde?]. Med Sci (Paris). 2008;24(6-7):579-580.
5. Delcombel R, et al. New prospects in the roles of the C-termi-nal domains of VEGF-A and their cooperation for ligand binding, cellular signaling and vessels formation. Angiogenesis. 2013;16(2): 353-371.
6. Labied S, et al. Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xeno-transplantation. Transplantation. 2013;95(3):426-433.
7. Padulo J, Oliva F, Frizziero A, Maffulli N. Muscle, Ligaments and Tendons Journal. Basic principles and recommendations in clinical and field science research. MLTJ. 2013;4:250-252.
8. Kaux JF, et al. Effects of platelet-rich plasma (PRP) on the healing of Achilles tendons of rats. Wound Repair Regen. 2012;20(5):748-756.
9. Wieloch P, et al. A cryo-jaw designed for in vitro tensile testing of the healing Achilles endons in rats. J Biomech. 2004;37(11): 1719-1722.
10. Lambert CA, et al. Distinct pathways in the over-expression of matrix metalloproteinases in human fibroblasts by relaxation of mechanical tension. Matrix Biol. 2001;20(7):397-408.
11. George JN. Platelets. Lancet. 2000;355(9214):1531-1539.
12. Nurden AT, et al. Platelets and wound healing. Front Biosci. 2008;13: 3532-3548.
13. Nakama LH, et al. VEGF, VEGFR-1, and CTGF cell densities in tendon are increased with cyclical loading: An in vivo tendinopathy model. J Orthop Res. 2006;24(3):393-400.
14. Scott A, et al. VEGF expression in patellar tendinopathy: a preliminary study. Clin Orthop Relat Res. 2008;466(7):1598-1604.
15. Wang XT, Liu PY, Tang JB. Tendon healing in vitro: modification of tenocytes with exogenous vascular endothelial growth factor gene increases expression of transforming growth factor beta but minimally affects expression of collagen genes. J Hand Surg Am. 2005;30(2):222-229.
16. Hou Y, et al. Effects of transforming growth factor-beta1 and vascular endothelial growth factor 165 gene transfer on Achilles tendon healing. Matrix Biol. 2009;28(6): 324-335.
17. Sahin H, et al. Impaired biomechanical properties correlate with neoangiogenesis as well as VEGF and MMP-3 expression during rat patellar tendon healing. J Orthop Res. 2012;30 (12):1952-1957.
18. Chen J, et al. Sodium hyaluronate as a drug-release system for VEGF 165 improves graft revascularization in anterior cruciate ligament reconstruction in a rabbit model. Exp Ther Med. 2012;4(3):430-434.
19. Kaux JF, et al. Eccentric training improves tendon biomechanical properties: a rat model. J Orthop Res. 2013;31(1):119-124.